These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 33390287)

  • 1. Corrigendum to "Polypyrimidine tract binding protein 1 promotes lymphatic metastasis and proliferation of bladder cancer via alternative splicing of MEIS2 and PKM." [Canc. Lett. 449 (2019) 31-44].
    Xie R; Chen X; Chen Z; Huang M; Dong W; Gu P; Zhang J; Zhou Q; Dong W; Han J; Wang X; Li H; Huang J; Lin T
    Cancer Lett; 2021 Mar; 500():292-293. PubMed ID: 33390287
    [No Abstract]   [Full Text] [Related]  

  • 2. Polypyrimidine tract binding protein 1 promotes lymphatic metastasis and proliferation of bladder cancer via alternative splicing of MEIS2 and PKM.
    Xie R; Chen X; Chen Z; Huang M; Dong W; Gu P; Zhang J; Zhou Q; Dong W; Han J; Wang X; Li H; Huang J; Lin T
    Cancer Lett; 2019 May; 449():31-44. PubMed ID: 30742945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Erratum: Polypyrimidine Tract-Binding Protein 1 promotes proliferation, migration and invasion in clear-cell renal cell carcinoma by regulating alternative splicing of PKM.
    Jiang J; Chen X; Liu H; Shao J; Xie R; Gu P; Duan C
    Am J Cancer Res; 2021; 11(1):297-300. PubMed ID: 33520375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RBM4 Regulates Neuronal Differentiation of Mesenchymal Stem Cells by Modulating Alternative Splicing of Pyruvate Kinase M.
    Su CH; Hung KY; Hung SC; Tarn WY
    Mol Cell Biol; 2017 Feb; 37(3):. PubMed ID: 27821480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic and Proliferative State of Vascular Adventitial Fibroblasts in Pulmonary Hypertension Is Regulated Through a MicroRNA-124/PTBP1 (Polypyrimidine Tract Binding Protein 1)/Pyruvate Kinase Muscle Axis.
    Zhang H; Wang D; Li M; Plecitá-Hlavatá L; D'Alessandro A; Tauber J; Riddle S; Kumar S; Flockton A; McKeon BA; Frid MG; Reisz JA; Caruso P; El Kasmi KC; Ježek P; Morrell NW; Hu CJ; Stenmark KR
    Circulation; 2017 Dec; 136(25):2468-2485. PubMed ID: 28972001
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Corrigendum to "Macrophage-expressed CD51 promotes cancer stem cell properties via the TGF-β1/smad2/3 axis in pancreatic cancer" [Canc. Lett. 459(2019)204-215].
    Zhang B; Ye H; Ren X; Zheng S; Zhou Q; Chen C; Lin Q; Li G; Wei L; Fu Z; Zhang Y; Hu C; Li Z; Chen R
    Cancer Lett; 2022 Nov; 548():215897. PubMed ID: 36050250
    [No Abstract]   [Full Text] [Related]  

  • 7. Corrigendum to "UBE2T promotes radiation resistance in non-small cell lung cancer via inducing epithelial-mesenchymal transition and the ubiquitination-mediated FOXO1 degradation" [Canc. Lett. 494 (2020) 121-131].
    Yin H; Wang X; Zhang X; Zeng Y; Xu Q; Wang W; Zhou F; Zhou Y
    Cancer Lett; 2022 Sep; 543():215792. PubMed ID: 35718664
    [No Abstract]   [Full Text] [Related]  

  • 8. Corrigendum to "Identification of a CIP4 PKA phosphorylation site involved in the regulation of cancer cell invasiveness and metastasis" [Canc. Lett. 461 (2019) 65-77].
    Tonucci FM; Almada E; Borini-Etichetti C; Pariani A; Hidalgo F; Rico MJ; Girardini J; Favre C; Goldenring JR; Menacho-Marquez M; Larocca MC
    Cancer Lett; 2020 Mar; 473():200-201. PubMed ID: 31932121
    [No Abstract]   [Full Text] [Related]  

  • 9. Corrigendum to "Voltage-gated sodium channel Nav1.5 promotes tumor progression and enhances chemosensitivity to 5-fluorouracil in colorectal cancer" [Canc. Lett. 500 (2021) 119-131].
    Sui Q; Peng J; Han K; Lin J; Zhang R; Ou Q; Qin J; Deng Y; Zhou W; Kong L; Tang J; Xiao B; Li Y; Yu L; Fang Y; Ding PR; Pan Z
    Cancer Lett; 2021 Sep; 516():57-60. PubMed ID: 34091433
    [No Abstract]   [Full Text] [Related]  

  • 10. Polypyrimidine tract sequences direct selection of alternative branch sites and influence protein binding.
    Norton PA
    Nucleic Acids Res; 1994 Sep; 22(19):3854-60. PubMed ID: 7937104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Corrigendum to "Rab8A promotes breast cancer progression by increasing surface expression of Tropomyosin-related kinase B" [Canc. Lett. 535 (2022) 215629].
    Liu Y; Zhang Z; Gao X; Ma Q; Yu Z; Huang S
    Cancer Lett; 2022 Jul; 539():215701. PubMed ID: 35527117
    [No Abstract]   [Full Text] [Related]  

  • 12. Corrigendum to "SUMOylation of SYNJ2BP-COX16 promotes breast cancer progression through DRP1-mediated mitochondrial fission" [Canc. Lett. 547 (2022) 215871].
    Wang M; Wei R; Li G; Bi HL; Jia Z; Zhang M; Pang M; Li X; Ma L; Tang Y
    Cancer Lett; 2022 Nov; 549():215923. PubMed ID: 36166936
    [No Abstract]   [Full Text] [Related]  

  • 13. Suggestive evidence on the involvement of polypyrimidine-tract binding protein in regulating alternative splicing of MAP/microtubule affinity-regulating kinase 4 in glioma.
    Fontana L; Rovina D; Novielli C; Maffioli E; Tedeschi G; Magnani I; Larizza L
    Cancer Lett; 2015 Apr; 359(1):87-96. PubMed ID: 25578778
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SRSF3, a Splicer of the PKM Gene, Regulates Cell Growth and Maintenance of Cancer-Specific Energy Metabolism in Colon Cancer Cells.
    Kuranaga Y; Sugito N; Shinohara H; Tsujino T; Taniguchi K; Komura K; Ito Y; Soga T; Akao Y
    Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30279379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Corrigendum to "AGBL2 promotes cancer cell growth through IRGM-regulated autophagy and enhanced Aurora A activity in hepatocellular carcinoma" [Canc. Lett. 414 (2018) 71-80].
    Wang LL; Jin XH; Cai MY; Li HG; Chen JW; Wang FW; Wang CY; Hu WW; Liu F; Xie D
    Cancer Lett; 2022 Jul; 539():215700. PubMed ID: 35525812
    [No Abstract]   [Full Text] [Related]  

  • 16. Corrigendum to "DGKA interacts with SRC/FAK to promote the metastasis of non-small cell lung cancer" [Canc. Lett. (2022 Apr 28) 532 215585].
    Fu L; Deng R; Huang Y; Yang X; Jiang N; Zhou J; Lin C; Chen S; Wu L; Cui Q; Yun J
    Cancer Lett; 2022 Jul; 539():215696. PubMed ID: 35477591
    [No Abstract]   [Full Text] [Related]  

  • 17. Corrigendum to "MicroRNA-21 suppresses PTEN and hSulf-1 expression and promotes hepatocellular carcinoma progression through AKT/ERK pathways" [Canc. Lett. 337 (2013) 226-236].
    Bao L; Yan Y; Xu C; Ji W; Shen S; Xu G; Zeng Y; Sun B; Qian H; Chen L; Wu M; Chen J; Su C
    Cancer Lett; 2020 Mar; 473():198-199. PubMed ID: 31926781
    [No Abstract]   [Full Text] [Related]  

  • 18. Corrigendum to "Exosome-encapsulated miRNAs contribute to CXCL12/CXCR4-induced liver metastasis of colorectal cancer by enhancing M2 polarization of macrophages" [Canc. Lett. 474 (2020) 36-52].
    Wang D; Wang X; Si M; Yang J; Sun S; Wu H; Cui S; Qu X; Yu X
    Cancer Lett; 2022 Jan; 525():200-202. PubMed ID: 34785089
    [No Abstract]   [Full Text] [Related]  

  • 19. Corrigendum to "NRF2/SHH signaling cascade promotes tumor-initiating cell lineage and drug resistance in hepatocellular carcinoma" [Canc. Lett. 476 (2020) 48-56].
    Leung HW; Lau EYT; Leung CON; Lei MML; Mok EHK; Ma VWS; Cho WCS; Ng IOL; Yun JP; Cai SH; Yu HJ; Ma S; Lee TKW
    Cancer Lett; 2021 Feb; 499():2. PubMed ID: 32563702
    [No Abstract]   [Full Text] [Related]  

  • 20. Corrigendum to "DIO3, the thyroid hormone inactivating enzyme, promotes tumorigenesis and metabolic reprogramming in high grade serous ovarian cancer" [Canc. Lett. 501 224-233].
    Moskovich D; Alfandari A; Finkelshtein Y; Weisz A; Katzav A; Kidron D; Edelstein E; Veroslavski D; Perets R; Arbib N; Kadan Y; Fishman A; Lerer B; Ellis M; Ashur-Fabian O
    Cancer Lett; 2023 Jun; 563():216196. PubMed ID: 37104919
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.